An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung Cancer
A Patient Cohort With Locally Advanced or Metastatic Non-small Cell Lung Cancer Treated With Tarceva (Erlotinib) Monotherapy and Not Progressing After at Least 9 Months
1 other identifier
observational
217
1 country
92
Brief Summary
This prospective, multi-center, observational study will assess the progression-free survival and safety of patients with locally advanced or metastatic non-small cell lung cancer treated with Tarceva (erlotinib) and not disease progressing after at least 9 months. Data will be collected for 24 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2010
Typical duration for all trials
92 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 6, 2011
CompletedFirst Posted
Study publicly available on registry
December 8, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedNovember 2, 2016
November 1, 2016
3.4 years
December 6, 2011
November 1, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Progression-free survival
24 months
Secondary Outcomes (5)
Best treatment response
24 months
Overall survival
24 months
Safety (incidence of adverse events)
24 months
Type of treatment response
24 months
Treatment compliance of patient
24 months
Study Arms (1)
Cohort
Eligibility Criteria
Adult patients with non-small cell lung cancer
You may qualify if:
- Adult patients, \>/=18 years of age
- Diagnosis of locally advanced or metastatic non-small cell lung cancer (NSCLC, stage III/IV)
- Treatment with Tarceva monotherapy and not progressing after at least 9 months at the date of study start
You may not qualify if:
- Not agreeing to be followed-up (for a maximum of 24 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (92)
Unknown Facility
Abbeville, 80142, France
Unknown Facility
Agen, 47000, France
Unknown Facility
Aix-en-Provence, 13616, France
Unknown Facility
Aix-en-Provence, 13617, France
Unknown Facility
Ajaccio, 20176, France
Unknown Facility
Amiens, 80090, France
Unknown Facility
Angers, 49933, France
Unknown Facility
Annecy, 74000, France
Unknown Facility
Aubagne, 13400, France
Unknown Facility
Auxerre, 89000, France
Unknown Facility
Bastia, 20200, France
Unknown Facility
Bordeaux, 33077, France
Unknown Facility
Bourg-en-Bresse, 01012, France
Unknown Facility
Brest, 29200, France
Unknown Facility
Brest, 29240, France
Unknown Facility
Bron, 69677, France
Unknown Facility
Bry-sur-Marne, 94366, France
Unknown Facility
Caen, 14076, France
Unknown Facility
Cagnes-sur-Mer, 06805, France
Unknown Facility
Chalon-sur-Saône, 71100, France
Unknown Facility
Chambray-lès-Tours, 37175, France
Unknown Facility
Chaumont, 52014, France
Unknown Facility
Chauny, 02303, France
Unknown Facility
Cholet, 49325, France
Unknown Facility
Clamart, 92141, France
Unknown Facility
Clermont-Ferrand, 63003, France
Unknown Facility
Colmar, 68024, France
Unknown Facility
Compiègne, 60321, France
Unknown Facility
Coquelles, 62231, France
Unknown Facility
Cornebarrieu, 31700, France
Unknown Facility
Creil, 60109, France
Unknown Facility
Créteil, 94010, France
Unknown Facility
Dax, 40107, France
Unknown Facility
Dijon, 21079, France
Unknown Facility
Draguignan, 83007, France
Unknown Facility
Eaubonne, 95602, France
Unknown Facility
Fréjus, 83608, France
Unknown Facility
Gap, 05007, France
Unknown Facility
Gleizé, 69400, France
Unknown Facility
Helfaut, 62570, France
Unknown Facility
Hyères, 83400, France
Unknown Facility
La Chaussée-Saint-Victor, 41260, France
Unknown Facility
La Roche-sur-Yon, 85925, France
Unknown Facility
La Rochelle, 17019, France
Unknown Facility
La Source, 45100, France
Unknown Facility
La Tronche, 38700, France
Unknown Facility
Le Plessis-Robinson, 92350, France
Unknown Facility
Libourne, 33505, France
Unknown Facility
Limoges, 87042, France
Unknown Facility
Longjumeau, 91161, France
Unknown Facility
Lyon, 69275, France
Unknown Facility
Lyon, 69365, France
Unknown Facility
Meaux, 77104, France
Unknown Facility
Metz, 57000, France
Unknown Facility
Meudon, 92360, France
Unknown Facility
Montauban, 82013, France
Unknown Facility
Montpellier, 34070, France
Unknown Facility
Mulhouse, 68070, France
Unknown Facility
Nancy, 54100, France
Unknown Facility
Nantes, 44202, France
Unknown Facility
Nevers, 58033, France
Unknown Facility
Paris, 75230, France
Unknown Facility
Paris, 75571, France
Unknown Facility
Paris, 75908, France
Unknown Facility
Perpignan, 66012, France
Unknown Facility
Perpignan, 66046, France
Unknown Facility
Pierre-Bénite, 69495, France
Unknown Facility
Pontoise, 95300, France
Unknown Facility
Reims, 51056, France
Unknown Facility
Reims, 51057, France
Unknown Facility
Rennes, 35033, France
Unknown Facility
Rouen, 76000, France
Unknown Facility
Saint-Aubin-lès-Elbeuf, 76410, France
Unknown Facility
Saint-Avold, 57502, France
Unknown Facility
Saint-Brieuc, 22027, France
Unknown Facility
Saint-Jean, 31240, France
Unknown Facility
Saint-Priest-en-Jarez, 42271, France
Unknown Facility
Saint-Priest-en-Jarez, 42770, France
Unknown Facility
Saint-Quentin, 02321, France
Unknown Facility
Salon-de-Provence, 13300, France
Unknown Facility
Senlis, 60309, France
Unknown Facility
Strasbourg, 67010, France
Unknown Facility
Strasbourg, 67065, France
Unknown Facility
Strasbourg, 67091, France
Unknown Facility
Tarbes, 65000, France
Unknown Facility
Thionville, 57126, France
Unknown Facility
Toulon, 83041, France
Unknown Facility
Toulon, 83056, France
Unknown Facility
Toulouse, 31059, France
Unknown Facility
Tours, 37044, France
Unknown Facility
Vénissieux, 69200, France
Unknown Facility
Vichy, 3201, France
Study Officials
- STUDY DIRECTOR
Clinical Trials
Hoffmann-La Roche
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2011
First Posted
December 8, 2011
Study Start
June 1, 2010
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
November 2, 2016
Record last verified: 2016-11